Stay updated with breaking news from Phil Bryan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Several countries are criticised for suspending inoculation over blood clot fears
Have European countries made a mistake in halting AstraZeneca shots? Here’s what health experts say Within the space of a few days, the rollout of the Oxford-AstraZeneca Covid-19 vaccine has ground to a standstill in virtually all of western Europe. France, Spain, Germany, Italy and more than a dozen other countries have paused rollout of the shot, calling it a precautionary measure following concerns that it could be linked to blood clots; decisions that go against the advice of global health agencies. A few countries have stood by the vaccine — including the United Kingdom, where more t...
2021-03-17 15:36:03 GMT2021-03-17 23:36:03(Beijing Time) Xinhua English TALLINN, March 17 (Xinhua) -- At least 20 European countries have fully or partially suspended the use of the AstraZeneca coronavirus vaccine following reports of suspected deaths from blood clots after vaccination, which prompted the European Medicines Agency (EMA)'s investigation and the World Health Organization (WHO)'s safety review. On Tuesday, Sweden joined countries like Bulgaria, Denmark, Lithuania, Luxembourg, Latvia, the Netherlands, Ireland, France, Germany, Italy, Spain, Slovenia, Cyprus and Portugal to...
Link between cerebral blood clots and AstraZeneca vaccine 'not implausible', says German regulator Number of a certain type of blood clot was 'statistically significantly higher' than the expected figure, the regulator said 17 March 2021 • 1:03pm 17 European countries have suspended their AstraZeneca vaccine campaigns Credit: Hannibal Hanschke/Reuters The number of people suffering cerebral blood clots after receiving the AstraZeneca jab in Germany was “statistically significantly higher” than the number that would have been expected in the general population, according to a report from...